151 related articles for article (PubMed ID: 36209425)
1. Subtyping of cardiac amyloidosis by mass spectrometry-based proteomics of endomyocardial biopsies.
Noborn F; Thomsen C; Vorontsov E; Bobbio E; Sihlbom C; Nilsson J; Polte CL; Bollano E; Vukusic K; Sandstedt J; Dellgren G; Karason K; Oldfors A; Larson G
Amyloid; 2023 Mar; 30(1):96-108. PubMed ID: 36209425
[TBL] [Abstract][Full Text] [Related]
2. Classification of Amyloidosis by Model-Assisted Mass Spectrometry-Based Proteomics.
Palstrøm NB; Rojek AM; Møller HEH; Hansen CT; Matthiesen R; Rasmussen LM; Abildgaard N; Beck HC
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008745
[TBL] [Abstract][Full Text] [Related]
3. Mass spectrometric-based proteomic analysis of amyloid neuropathy type in nerve tissue.
Klein CJ; Vrana JA; Theis JD; Dyck PJ; Dyck PJ; Spinner RJ; Mauermann ML; Bergen HR; Zeldenrust SR; Dogan A
Arch Neurol; 2011 Feb; 68(2):195-9. PubMed ID: 20937937
[TBL] [Abstract][Full Text] [Related]
4. Pathology and Proteomics-Based Diagnosis of Localized Light-Chain Amyloidosis in Dogs and Cats.
Kadota A; Iwaide S; Miyazaki S; Mitsui I; Machida N; Murakami T
Vet Pathol; 2020 Sep; 57(5):658-665. PubMed ID: 32880234
[TBL] [Abstract][Full Text] [Related]
5. Disappearance of immunoglobulins from persistent renal amyloid deposits following stem cell transplantation for heavy-and light-chain amyloidosis.
Safadi S; Saad A; Quint PS; Sethi S; Leung N; Kurtin P; Nasr SH
Nephrol Dial Transplant; 2015 Jul; 30(7):1151-5. PubMed ID: 25796445
[TBL] [Abstract][Full Text] [Related]
6. Relationship between monoclonal gammopathy and cardiac amyloid type.
Maleszewski JJ; Murray DL; Dispenzieri A; Grogan M; Pereira NL; Jenkins SM; Judge DP; Caturegli P; Vrana JA; Theis JD; Dogan A; Halushka MK
Cardiovasc Pathol; 2013; 22(3):189-94. PubMed ID: 23102805
[TBL] [Abstract][Full Text] [Related]
7. Confirming the Diagnosis of Amyloidosis.
Wisniowski B; Wechalekar A
Acta Haematol; 2020; 143(4):312-321. PubMed ID: 32544917
[TBL] [Abstract][Full Text] [Related]
8. Implementation and evaluation of amyloidosis subtyping by laser-capture microdissection and tandem mass spectrometry.
Mollee P; Boros S; Loo D; Ruelcke JE; Lakis VA; Cao KL; Renaut P; Hill MM
Clin Proteomics; 2016; 13():30. PubMed ID: 27795698
[TBL] [Abstract][Full Text] [Related]
9. Strong transthyretin immunostaining: potential pitfall in cardiac amyloid typing.
Satoskar AA; Efebera Y; Hasan A; Brodsky S; Nadasdy G; Dogan A; Nadasdy T
Am J Surg Pathol; 2011 Nov; 35(11):1685-90. PubMed ID: 21945954
[TBL] [Abstract][Full Text] [Related]
10. [Classification of cardiac amyloidosis: an immunohistochemical analysis].
Li L; Duan XJ; Sun Y; Lu Y; Xu HY; Wang QZ; Wang HY
Zhonghua Bing Li Xue Za Zhi; 2018 Feb; 47(2):105-109. PubMed ID: 29429161
[No Abstract] [Full Text] [Related]
11. Precise diagnosis and typing of early-stage renal immunoglobulin-derived amyloidosis by label-free quantification of parallel reaction monitoring-based targeted proteomics.
Li Y; Zhang Y; Zhou X; Xue X; Wang M; Kang D; Zhou Y; Hu R; Quan S; Xing G; Yang J
BMC Nephrol; 2023 Mar; 24(1):50. PubMed ID: 36894904
[TBL] [Abstract][Full Text] [Related]
12. Imaging mass spectrometry analysis of renal amyloidosis biopsies reveals protein co-localization with amyloid deposits.
Casadonte R; Kriegsmann M; Deininger SO; Amann K; Paape R; Belau E; Suckau D; Fuchser J; Beckmann J; Becker M; Kriegsmann J
Anal Bioanal Chem; 2015 Jul; 407(18):5323-31. PubMed ID: 25935672
[TBL] [Abstract][Full Text] [Related]
13. Sensitive, Simple, and Robust Nano-Liquid Chromatography-Mass Spectrometry Method for Amyloid Protein Subtyping.
Payto D; Heideloff C; Wang S
Methods Mol Biol; 2016; 1378():55-60. PubMed ID: 26602117
[TBL] [Abstract][Full Text] [Related]
14. Correlation of histomorphological pattern of cardiac amyloid deposition with amyloid type: a histological and proteomic analysis of 108 cases.
Larsen BT; Mereuta OM; Dasari S; Fayyaz AU; Theis JD; Vrana JA; Grogan M; Dogan A; Dispenzieri A; Edwards WD; Kurtin PJ; Maleszewski JJ
Histopathology; 2016 Apr; 68(5):648-56. PubMed ID: 26212778
[TBL] [Abstract][Full Text] [Related]
15. Quantitative proteome profiling provides evidence of an activation of the complement cascade in ATTR amyloidosis.
Treitz C; Gottwald J; Gericke E; Urban P; Meliß RR; Axmann HD; Siebert F; Becker K; Tholey A; Röcken C
Amyloid; 2022 Jun; 29(2):102-109. PubMed ID: 34913770
[TBL] [Abstract][Full Text] [Related]
16. Non-cardiac biopsy sites with high frequency of transthyretin amyloidosis.
Dasari S; Dispenzieri A; Mansour S; Muppa P; Kurtin PJ; Theis JD; Vrana JA; Grogan M; Kourelis T; Gertz MA; McPhail ED
ESC Heart Fail; 2021 Feb; 8(1):750-755. PubMed ID: 33277823
[TBL] [Abstract][Full Text] [Related]
17. Biochemical characterisation of amyloid by endomyocardial biopsy.
Benson MD; Breall J; Cummings OW; Liepnieks JJ
Amyloid; 2009 Mar; 16(1):9-14. PubMed ID: 19291509
[TBL] [Abstract][Full Text] [Related]
18. Immunoelectron microscopy and mass spectrometry for classification of amyloid deposits.
Abildgaard N; Rojek AM; Møller HE; Palstrøm NB; Nyvold CG; Rasmussen LM; Hansen CT; Beck HC; Marcussen N
Amyloid; 2020 Mar; 27(1):59-66. PubMed ID: 31752543
[TBL] [Abstract][Full Text] [Related]
19. Classification of amyloid deposits in diagnostic cardiac specimens by immunofluorescence.
Collins AB; Smith RN; Stone JR
Cardiovasc Pathol; 2009; 18(4):205-16. PubMed ID: 18619857
[TBL] [Abstract][Full Text] [Related]
20. Isolated heart transplantation for familial transthyretin (TTR) V122I cardiac amyloidosis.
Thenappan T; Fedson S; Rich J; Murks C; Husain A; Pogoriler J; Anderson AS
Amyloid; 2014 Jun; 21(2):120-3. PubMed ID: 24818650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
